Patient-reported preferences for subcutaneous or intravenous administration of parenteral drug treatments in adults with immune disorders: a systematic review and meta-analysis
Aim: Several studies have found subcutaneous (SC) and intravenous (IV) administration of similar drugs for long-lasting immunological and autoimmune diseases to have similar clinical effectiveness, meaning that what patients report they prefer is, or should be, a major factor in treatment choices. T...
Saved in:
Main Authors: | Vera Bril (Author), Johannes Lampe (Author), Nichola Cooper (Author), Peter Kiessling (Author), Ann Gardulf (Author) |
---|---|
Format: | Book |
Published: |
Becaris Publishing Limited,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Payer Perspectives on Intravenous versus Subcutaneous Administration of Drugs
by: Epstein RS
Published: (2021) -
Pharmacokinetics of placental protein 13 after intravenous and subcutaneous administration in rabbits
by: Drobnjak T, et al.
Published: (2018) -
Comparative Cost Analysis Of Intravenous And Subcutaneous Administration Of Rituximab In Lymphoma Patients
by: Delgado Sánchez O, et al.
Published: (2019) -
Role of the nurse in the short stay immunotherapy Unit during the administration of intravenous anda subcutaneous gammaglobulin
by: Rosales Sánchez Isis, et al.
Published: (2014) -
Pharmacokinetics of Tildipirosin in Plasma, Milk, and Somatic Cells Following Intravenous, Intramuscular, and Subcutaneous Administration in Dairy Goats
by: Juan Sebastián Galecio, et al.
Published: (2022)